Global Medical/Diagnostic Imaging Market - Strategic Insights and Forecasts (2026-2031)

The Global Medical and Diagnostic Imaging Market is projected to expand at a CAGR of 5.0%, reaching USD 60.7 billion in 2031 from USD 47.5 billion in 2026.

Diagnostic imaging is becoming an integrated hardware-software infrastructure layer rather than a collection of isolated scanners. Healthcare systems increasingly evaluate imaging purchases on system uptime, scan throughput, dose efficiency, reconstruction speed, interoperability and long-term upgradeability. This is changing procurement in favor of platforms that combine modality hardware with AI-enabled acquisition, reconstruction, protocol automation, remote service and enterprise image management. The trend is particularly visible in large hospital networks, where standardized software and remote reading can improve utilization across multiple sites.

Large imaging vendors continue to invest across hardware, software and lifecycle services. GE HealthCare, Siemens Healthineers and Philips are expanding their imaging platforms with new scanner architectures, workflow software and enterprise imaging capabilities. This broadens competition beyond equipment specifications and increases the importance of software integration, service quality and long-term upgrade paths.

Regulatory activity also shows how rapidly the installed base is being software-enabled. The U.S. FDA's AI-enabled medical device list contains a large concentration of radiology products, including 2026 clearances for CT reconstruction, mammography, ultrasound, MRI, PACS and image-analysis software. This creates a recurring upgrade layer around installed imaging equipment and raises the strategic importance of vendor-neutral and cloud-based enterprise imaging platforms. GE HealthCare's March 2026 acquisition of Intelerad for approximately USD 2.3 billion illustrates the shift toward combining scanner portfolios with recurring software and workflow revenue.

Market Trends

• Photon-Counting and Spectral CT Are Redefining Premium CT

CT innovation is moving toward detector architectures that capture more information from each X-ray interaction. GE HealthCare received FDA clearance for Photonova Spectra in March 2026, using an 8-bin photon-counting architecture, while Philips received FDA clearance for Verida detector-based spectral CT in April 2026. These systems aim to increase material discrimination, spatial resolution and quantitative information while reducing the need for separate acquisition protocols. Adoption will initially be concentrated in tertiary and high-volume centers because capital costs remain high, but the technology is likely to influence mainstream CT platform design through 2031.

• MRI Is Reducing Dependence on Liquid Helium

MRI vendors are redesigning magnets to reduce installation barriers and lifecycle exposure to liquid helium. Siemens Healthineers received FDA clearance in January 2026 for the 70 cm Magnetom Flow. 1.5T platform using DryCool technology, while GE HealthCare received clearance in February 2026 for SIGNA Sprint with Freelium, a sealed 1.5T magnet. Philips is also expanding its BlueSeal platform and introduced Titanion, an ultra-high-gradient 3T system, in May 2026. Lower-helium designs simplify siting, reduce quench infrastructure requirements and make high-field MRI more practical for outpatient and distributed imaging sites.

• AI Is Moving Upstream Into Acquisition and Reconstruction

Artificial intelligence is no longer limited to post-processing or diagnostic decision support. Vendors increasingly embed AI into patient positioning, protocol selection, motion correction, reconstruction, dose optimization and scan planning. Philips received FDA clearance for SmartHeart cardiac MR planning in March 2026, while GE HealthCare continues to expand deep-learning CT and MR reconstruction. By automating repeatable technical steps, these tools increase throughput and help imaging departments manage workforce shortages without lowering diagnostic quality.

• Enterprise Imaging Is Becoming Cloud-First

Large provider networks increasingly need imaging data to move across hospitals, outpatient sites, ambulatory centers and teleradiology operations. GE HealthCare completed its acquisition of Intelerad in March 2026 to accelerate a cloud-first enterprise imaging strategy. AGFA HealthCare, Sectra and other imaging informatics vendors continue to emphasize streaming viewers, worklist federation, vendor-neutral archives and cloud deployment. This software layer is growing faster than the installed hardware base because each health system must manage more studies, more modalities and more geographically distributed interpretation workflows.

• Distributed Care Is Increasing Demand for Compact and Flexible Systems

Imaging capacity is shifting beyond tertiary hospitals toward ambulatory and community settings. Portable and compact ultrasound, floor-mounted X-ray, lower-footprint MRI and standardized mid-range CT platforms allow providers to add diagnostic capacity without the infrastructure of a major hospital radiology department. Shimadzu's March 2026 RADspeed Pro XF floor-mounted system and Fujifilm India's January 2026 launch of new CT, mammography, radiography and healthcare IT platforms reflect continued demand for systems designed around installation flexibility and workflow efficiency.

Market Drivers

• Rising Diagnostic Demand Across Chronic Diseases

Cancer, cardiovascular disease, neurological disorders and musculoskeletal conditions require repeated use of CT, MRI, X-ray, ultrasound and molecular imaging across screening, diagnosis, staging, treatment planning and follow-up. As populations age and chronic disease management becomes more imaging-intensive, procedure volumes rise even in markets where scanner penetration is already high. This supports replacement cycles and capacity expansion rather than depending only on new hospital construction.

• Replacement of Aging Installed Equipment

Much of the demand in North America, Western Europe and Japan comes from replacement and technology refresh rather than first-time installation. Hospitals replace systems to improve throughput, reduce energy and helium use, add AI-enabled reconstruction, meet cybersecurity requirements and reduce downtime. New platforms that deliver material clinical or operational benefits can therefore gain share even when the number of scanning rooms grows slowly.

• Outpatient and Ambulatory Imaging Expansion

Independent diagnostic centers and ambulatory networks are increasing their share of routine MRI, CT, ultrasound and X-ray procedures. These sites favor systems with lower siting requirements, rapid installation, high throughput and predictable service costs. The shift broadens demand beyond flagship premium systems and supports mid-range platforms that can deliver advanced image quality with simpler operating requirements.

• AI and Workflow Automation Improve Scanner Productivity

Staffing constraints are making productivity an increasingly important purchase criterion. Automated positioning, protocol selection, reconstruction, quality checks and worklist orchestration allow departments to process more studies with existing staff. The economic value of these tools is strongest in high-volume CT, MRI and ultrasound environments, where even modest reductions in scan time can materially increase daily capacity.

Market Restraints

• High Capital Cost and Long Procurement Cycles

High-field MRI, advanced CT and molecular imaging systems require substantial capital expenditure, room preparation and long-term service support. Budget constraints can delay replacement cycles, particularly in public hospitals and emerging markets. Procurement can also involve multi-year planning, tenders and reimbursement considerations, making revenue timing sensitive to institutional budgets.

• Regulatory, Cybersecurity and Interoperability Requirements

Imaging systems increasingly combine regulated hardware, software, AI and network connectivity. Manufacturers must maintain cybersecurity, software lifecycle controls, data privacy and interoperability across long equipment lifetimes. The regulatory burden is especially important for AI-enabled software that can materially affect image reconstruction or diagnosis. These requirements increase validation costs and can slow deployment of smaller software developers into hospital imaging environments.

• Supply-Chain Exposure to Specialized Components

MRI magnets, detector materials, X-ray tubes, high-voltage generators, semiconductors and specialized electronics have limited qualified supplier bases. Although manufacturers are increasing regional sourcing and redesigning systems to reduce dependence on scarce inputs such as liquid helium, component bottlenecks can still lengthen lead times and raise system costs.

Segment Analysis

• By Offering - Imaging Systems

Imaging systems remain the dominant offering because CT, MRI, X-ray, ultrasound and molecular imaging equipment account for most market value. Hardware demand is increasingly bundled with embedded software, AI reconstruction and multi-year upgrade paths. Imaging software and informatics grow faster from a smaller base as hospitals consolidate PACS, cloud viewing, workflow orchestration and AI applications across multi-site networks. The strategic distinction between hardware and software is therefore narrowing as major OEMs build recurring digital revenue around their installed scanner base.

• By Imaging Modality - Magnetic Resonance Imaging

MRI is estimated to contribute about 29% of global market value in 2026 and remains the largest modality by revenue because high-field systems command substantial average selling prices and are widely used in neurology, musculoskeletal imaging, oncology and cardiovascular care. Through 2031, MRI growth is supported by helium-light magnets, faster reconstruction, improved motion correction and workflow automation. CT grows at a similar pace as photon-counting and spectral systems increase the value of premium installations, while ultrasound expands through point-of-care and portable platforms.

• By End User - Hospitals

Hospitals remain the largest end-user group and are projected to generate approximately USD 39.5 billion of market demand by 2031. Large hospitals require broad modality coverage for emergency, inpatient, surgical, oncology and specialty pathways, and they increasingly purchase imaging as an integrated technology environment rather than as isolated systems. Diagnostic centers grow faster as outpatient imaging expands, particularly for MRI, CT, mammography and ultrasound.

• By Application - Oncology

Oncology is one of the largest and most technology-intensive application areas because imaging is required for detection, staging, biopsy guidance, radiotherapy planning, response assessment and surveillance. CT remains central to thoracic and abdominal oncology, MRI is critical for brain, liver, prostate and soft-tissue assessment, and PET/CT or PET/MR support metabolic and theranostic pathways. Cardiovascular and neurological imaging also remain major demand areas, with advanced CT, MRI and ultrasound increasingly using AI-assisted acquisition and quantification.

• By Geography - North America

North America remains the largest regional market and is projected to approach USD 21.6 billion by 2031. The United States combines high imaging utilization, a large installed base, strong outpatient networks and rapid uptake of new CT, MRI and imaging-software platforms. Europe remains a major replacement market with strong regulation and enterprise imaging adoption, while Asia Pacific expands faster through healthcare infrastructure investment, domestic manufacturing and growing access to advanced diagnostic services in China, India and Southeast Asia.

Competitive Environment

Siemens Healthineers and GE HealthCare maintain broad portfolios across CT, MRI, molecular imaging and X-ray. Siemens is strengthening its position through photon-counting CT and low-helium MRI, whereas, GE HealthCare is expanding photon-counting CT, sealed MRI systems and enterprise imaging software.

In addition, Philips competes across MRI, CT, ultrasound, image-guided therapy and imaging informatics. Its recent launches emphasize spectral CT, advanced MRI and AI-assisted scan planning. Furthermore, Canon Medical Systems remains strong in CT, MRI, ultrasound and angiography and Fujifilm Healthcare combines CT, mammography, digital radiography, ultrasound and healthcare IT. United Imaging Healthcare continues to expand internationally across CT, MRI and molecular imaging.

Recent Developments

• September 2026: GE HealthCare announced StarGuide GX, a next-generation 4D CZT SPECT/CT platform that had received CE Mark and was 510(k) pending in the United States.

• August 2026: The Philips-coordinated COMBINE-CT project moved into clinical validation across five studies using AI-enabled CT and spectral CT for coronary artery disease pathways.

• May 2026: Philips introduced Titanion, an ultra-high-gradient 3.0T MRI system designed for advanced microstructural and quantitative whole-body imaging.

• April 2026: Philips received FDA clearance for Verida detector-based spectral CT and the Rembra CT platform, expanding its next-generation CT portfolio.

• March 2026: GE HealthCare received FDA clearance for Photonova Spectra photon-counting CT and completed its USD 2.3 billion acquisition of Intelerad.

• January 2026: Siemens Healthineers received FDA clearance for the 70 cm Magnetom Flow. 1.5T MRI platform using virtually helium-free DryCool technology.

Medical/Diagnostic Imaging Market Scope